Autobio

Forecast & Rating5 analysts currently cover Autobio, with about 80.0% giving a positive rating — meaning they expect the stock to rise. The average price target is ¥39.42, about 14.7% upside from the current price of ¥34.36. Price targets span a fair range, indicating some disagreement among institutions. Historically, about 37.2% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study Autobio closely still see room for the stock to rise. Data as of Aug 4, 2026; for reference only and not investment advice.